Alexopoulou , A.,Karayiannis , P., 2015.Interferonbased combination treatment for chronic hepatitis C in the era of direct acting antivirals,Annls 28 55 -
Asahina , Y.,Tsuchiya , K.,Tamaki , N.,Hirayama , I.,Tanaka , T.,Sato , M.,Yasui , Y.,Hosokawa , T.,Ueda , K.,Kuzuya , T., 2010.Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection,Hepatology 52 518 -527
Attaullah , S.,Khan , S.,Ali , I., 2011.Hepatitis C virus genotypes in Pakistan: A systemic review,Virol. J. 8 8 -
Aziz , H.,AminAthar,M. , Murtaza,S. , Irfan,J. , Waheed,Y. and Bilal,I., 2011.Predictors of response to antiviral therapy in patients with chronic hepatitis C from Pakistani population. Chinese med, 124 1333 -
Borroni , G.,Andreoletti , M.,Casiraghi , M.,Ceriani , R.,Guerzoni , P.,Omazzi , B.,TERRENI,Salerno , F., 2008.Effectiveness of pegylated interferon/ ribavirin combination in 'real world'patients with chronic hepatitis C virus infection,Aliment. Pharmacol. Therapeut. 03657 2036 -797
Brown, 2005.Hepatitis C and liver transplantation,Nature 436 973 -
Chen , A.Y.,Zeremski , M.,Chauhan , R.,Jacobson , I.M.,Talal , A.H.,Michalak , T.I., 2013.Persistence of hepatitis C virus during and after otherwise clinically successful treatment of chronic hepatitis C with standard pegylated interferon α-2b and ribavirin therapy,PLoS One 8 -
Chou , R.,Hartung , D.,Rahman , B.,Wasson , N.,Cottrell , E.,Fu , R.,-,-EF, 2018.Treatment for hepatitis C virus infection in adults. Comparative effectiveness review No. 76. Agency for Healthcare Research and Quality,on 09 September 12 -
de Mattos , A.A. and de Mattos, Â. Z., 2010.Treatment of HCV infection in patients with cirrhosis,Annls. Hepatol. 9 80 -83
Dogan,Akin , M.S.,Yalaki , S., 2013.Sustained virological response based on the week 4 response in hepatitis C virus genotype 1 patients treated with peginterferons α-2a and α-2b, plus ribavirin,Eur. J. Gastroenterol. Hepatol. 25 1317 -1320
Dou , Z.,Chen,Xu , J.,Y. , Jiao,J.H. , Durako,S. , Zhao,Y. , Zhao,D. , Fang,H.,Zhang, 2002.Changing baseline characteristics among patients in the China national free antiretroviral treatment program,, 39 56 -64
Duffy , S.,Shackelton , L.A.,Holmes , E.C., 2008.Rates of evolutionary change in viruses: Patterns and determinants,Nat. Rev. Genet 9 267 -
Ekstrom , V.,Kumar , R.,Zhao , Y.,Yee , M.L.,Sung , C.,Toh , D.,Loh , P.Y.,Tan , J.,Teo , E. K.,Chow , W.C., 2016.Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism,Gastroenterol. Rep 5 208 -212
Feld , J.J.,Hoofnagle , J.H., 2005.Mechanism of action of interferon and ribavirin in treatment of hepatitis C,Nature 436 967 -
Ferenci , P.,Fried , M.W.,Shiffman , M.L.,Smith , C.I.,Marinos , G.,Gonçales , F.L.,Häussinger , D.,Diago , M.,Carosi , G.,Dhumeaux , D., 2005.Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin, 04 425 -433
Gale,Foy , E.M., 2005.Evasion of intracellular host defence by hepatitis C virus,Nature 436 939 -
Higgins , J.A.,Nasarabadi , S.,Karns , J.S.,Shelton , D.R.,Cooper , M.,Gbakima , A.,Koopman , R.P., 2003.A handheld real time thermal cycler for bacterial pathogen detection,Biosens 5663 00252 -1123
Hou , J., van Oord, G.,Groothuismink , Z.M.,Claassen , M.A.,Kreefft , K.,Zaaraoui-Boutahar,van Ijcken , W.F.,Osterhaus , A.D.,Janssen , H.L.,Andeweg , A.C., 2014.Gene expression profiling to predict and assess the consequences of therapyinduced virus eradication in chronic hepatitis C virus infection,J. Virol. 88 14 -12264
Idrees , M.,Riazuddin , S., 2008.Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission,BMC Infect. Dis. 8 1471 -
Jacobson , I.M., 2009.Treatment options for patients with chronic hepatitis C not responding to initial antiviral therapy,Clin. Gastroenterol 03 921 -930
Jehangir , K.,Khan , B.,Ayaz , A.,Muhammad , S.,Khalid , K., 2018.Hepatitis-C virus prevalence in district Shangla and evaluation of screening tests for anti-HCV, 50 1299 -1305
Khan , N.,Akmal , M.,Hayat , M.,Umar , M.,Ullah , A.,Ahmed , I.,Rahim , K.,Ali , S.,Bahadar , S.,Saleha , S., 2014.Geographic distribution of hepatitis C virus genotypes in pakistan,Hepatitis Monthly 14 -
Kim , W.R.,Flamm , S.L.,di Bisceglie , A.M.,Bodenheimer , H.C., 2008.Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease,Hepatology 47 1363 -1370
Klevens , R.M.,Hu , D.J.,Jiles , R.,Holmberg , S.D., 2012.Evolving epidemiology of hepatitis C virus in the United States,Clin. Infect. Dis. 55 S3 -S9
Malik , A.,-, 2016.-patients-in-Pakistan, -
Marinho , R.T.,Barreira , D.P., i40.Hepatitis C, stigma,World J. Gastroenterol. 19 6703 -
Messina , J.P.,Humphreys , I.,Flaxman , A.,Brown , A.,Cooke , G.S.,Pybus , O.G.,Barnes , E., 2015.Global distribution and prevalence of hepatitis C virus genotypes,Hepatology 61 77 -87
Ohno , O.,Mizokami , M.,Wu , R.R.,Saleh , M.G.,Ohba , K.I.,Orito , E.,Mukaide , M.,Williams , R.,Lau , J., 3b.New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a,J. clin. Microbiol 35 201 -207
Pearlman , B.L.,Traub , N., 2011.Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: A cure and so much more,Clin. Infect. Dis. 52 889 -900
Rosen , H.R., 2011.Chronic hepatitis C infection, 364 2429 -2438
Safi , S.,Badshah , Y.,Waheed , Y.,Fatima , K.,Tahir , S.,Shinwari , A.,Qadri , I., 2010.Distribution of hepatitis C virus genotypes, hepatic steatosis and their correlation with clinical and virological factors in Pakistan,-0032 4 253 -262
Shah , H.A.,Jafri , W.,Malik , I.,Prescott , L.,Simmonds , P.,Gastroenterol, 1997.Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan, 12 1746 -761
Simmonds , P.,Bukh , J.,Combet , C.,Deléage , G.,Enomoto , N.,Feinstone , S.,Halfon , P.,Inchauspé , G.,Kuiken , C.,Maertens , G., 2005.Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes,Hepatology 42 962 -973
Stoddard , M.B.,Li , H.,Wang , S.,Saeed , M.,Andrus , L.,Ding , W.,Jiang , X.,Learn , G. H.,VonSchaewen,M. and Wen,J., 2015.molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4, 6 02518 -14
Stuyver , L.J.,Mcbrayer , T.R.,Whitaker , T.,Tharnish , P.M.,Ramesh , M.,Lostia , S.,Cartee , L.,Shi , J.,Hobbs , A.,Schinazi , R.F., 2004.Inhibition of the subgenomic hepatitis C virus replicon in huh7 cells by 2′-deoxy-2′-fluorocytidine, 48 651 -654
Ticehurst , J.R.,Hamzeh , F.M.,Thomas , D.L., 2007.Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis,J. clin. Microbiol 45 06 -2433
Tohme , R.A.,Holmberg , S.D., 2012.Transmission of hepatitis C virus infection through tattooing and piercing: a critical review,Clin. Infect. Dis. 54 1167 -1178
Veldt , B.J.,Heathcote , E.J.,Wedemeyer , H.,Reichen , J.,Hofmann , W.P.,Zeuzem , S.,Manns , M.P.,Hansen , B.E.,Schalm , S.W.,Janssen , H.L., 2007.Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis,Annls. Intern. Med 147 0003 -684
Waheed , Y.,Bhatti , A.,Ashraf , M., 2012.RNA dependent RNA polymerase of HCV: A potential target for the development of antiviral drugs,Infect. Genet 12 247 -257
Zhang , C.H.,Xu , G.L.,Jia , W.D.,Li , J.S.,J.L. and Ge,Y.S., 2011.Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: A meta-analysis of randomized controlled trials,Int. J. Cancer 129 1254 -1264